We also compared the healthy allogeneic stem cell donors with a group of myeloma patients receiving G-CSF treatment for mobilization of autologous stem cells; the myeloma patients then showed higher pre-harvesting osteopontin levels and a similar increase as the healthy donors following leukapheresis. Here, SPP1 is linked to plasma cell myeloma.